ASCO 2020: UK-first study shows feasibility of genetic screening for prostate cancer 01 Jun 2020 Genetic screening for prostate cancer in GP surgeries could be effective at picking up otherwise undiagnosed cases of the disease, a new pilot study shows. Find out more Show/Hide
ASCO 2020: Blood test predicts response to prostate cancer treatment 31 May 2020 A new blood test can predict how well men with advanced prostate cancer will respond to treatment and could replace some of the existing methods used to characterise and track the disease. Find out more Show/Hide
ASCO 2020: New optimised precision radiotherapy can reduce swallowing difficulties for head and neck cancer patients 30 May 2020 A new optimised intensity-modulated radiation therapy (IMRT) could spare head and neck cancer patients’ adverse life-long side effects after treatment, new clinical trial results have shown. Find out more Show/Hide
ASCO 2019: Breast cancer drug effective in 80 per cent of men with BRCA-mutant prostate cancer 05 Jun 2019
ASCO 2019: Immunotherapy better than aggressive chemotherapy as first treatment option for recurrent head and neck cancer 04 Jun 2019
ASCO 2017: Adding abiraterone to standard treatment improves prostate cancer survival by almost 40% 03 Jun 2017